Enter your login e-mail to the account
Search
- Rimegepant in the acute and preventive treatment of migraine
MUDr. Milan Maretta, PhD.
(3-4/2026, Interdisciplinary consilium ) - Mometasone furoate in the nose and bronchi: it does matter how and what do we treat inhaled allergy with
doc. MUDr. Martin Hrubiško, PhD.
(5/2013, Review articles ) - Hyperuricaemia in primary care
Doc. MUDr. Petr Němec, Ph.D.
(2/2021, Review articles ) - Comparison of efficacy and safety of atorvastatin in a dosage of 20 mg and 30 mg in general practitioners’ practice
MUDr. Martin Čaprnda, PhD., Mgr. Ján Farkašovský, PharmDr. Silvia Encingerová, Mgr. Oliver Tlčimuka
(5/2016, Original articles & case reports ) - General recommendations for safe pharmacotherapy in pregnancy in clinical practice
PharmDr. Kristína Podolská, PharmDr. Bc. Dana Mazánková, PhD., PharmDr. Mária Göböová, PhD.
(5/2025, Interdisciplinary consilium ) - ADVERSE DRUG REACTIONS, PHARMACOTHERAPEUTIC RISK
MUDr. Monika Laššánová, MUDr. Miriam Petrová, MUDr. Štefan Laššán, MUDr. Roman Hudec, PhD.
(2/2008, Spectrum ) - Ezetimibe in the treatment of hypercholesterolaemia
doc. MUDr. David Karásek, Ph.D.
(3/2020, Review articles ) - Antikoagulační léčba ve stáří
doc. MUDr. Jiří Špác, CSc.
(3/2018, Review articles ) - Safety treatment with statins
prof. MUDr. RNDr. Rudolf Pullmann, PhD.
(1/2014, Review articles )
- Ketamine in clinical psychiatry and addictology – a narrative review
MUDr. Ondřej Vašíček, MUDr. Tomáš Páleníček, Ph.D.
(3/2026, Review articles ) - The antidepressants treatment in patients with high cardiovascular risk: benefit or risk?
MUDr. Radkin Honzák, Milan Vrána
(6/2009, Review articles ) - Antidepressant medication in pedopsychiatry
MUDr. Dana Cesneková, MUDr. PhDr. Igor Hrtánek, PhD., MUDr. Andrea Hamráková, MUDr. Lukáš Peregrim
(1/2019, Review articles ) - Odborný program a abstrakty Psychiatria pre prax 9. ročník, 22. – 24. november 2024, Tatranská Lomnica
Kolektív autorov
(S2/2024, Supplement ) - SERTINDOL AND ITS HISTORY
prof. MUDr. Vladimír Novotný, CSc.
(4/2007, Psychopharmacology ) - Ziprasidone in the treatment of manic and mixed episodes of mild to moderate severity in patients with bipolar or schizoaffective disorder
MUDr. Dalibor Janoška, MUDr. Jozef Vido, MUDr. Petra Hermanová
(S1/2011, Original articles & case reports )
- CGRP monoclonal antibodies for migraine prophylaxis
MUDr. Tomáš Nežádal, Ph.D.
(5/2019, Review articles ) - Safety monitoring of escalation treatment of multiple sclerosis
MUDr. Jiří Piťha
(5/2019, Review articles ) - Glatiramer acetate: long-term immunomodulatory therapy in multiple sclerosis – safety, efficacy, adherence and persistence assesment
MUDr. Olga Zapletalová
(2/2016, Review articles ) - Porovnanie bezpečnosti a monitoringu DMD liekov prvej eskalačnej línie – dimetylfumarát, fingolimod, kladribin a okrelizumab
MUDr. Eva Kmeťová
(6/2018, Review articles ) - New treatment options for Neuromyelitis optica spectrum disorders (NMOSD)
prof. MUDr. Jarmila Szilasiová, PhD.
(3/2024, Review articles ) - Safety aspects of treating relapsing-remitting multiple sclerosis
MUDr. Radek Ampapa, MUDr. Stanislav Kopecký
(5/2016, Review articles ) - Fingolimod treatment of multiple sclerosis at any age
doc. MUDr. Radomír Taláb, CSc., MUDr. Marika Talábová
(2/2022, Review articles ) - SOUČASNÝ STAV A PERSPEKTIVY TROMBOLYTICKÉ TERAPIE (ČÁST II.)
MUDr. David Goldemund, MUDr. Robert Mikulík, MUDr. Michal Reif
(5/2007, Review articles ) - From genetic diagnostics to gene therapy in epileptology
MUDr. Ondřej Horák, doc. RNDr. Lenka Fajkusová, CSc., doc. MUDr. Hana Ošlejšková, Ph.D.
(2/2026, Main topic ) - Anti-CD20 therapy in relapsing-remitting multiple sclerosis: long term ofatumumab data in treatment naive patients
MUDr. Martin Karlík, PhD.
(2/2026, Information & comments ) - NEŽÁDOUCÍ ÚČINKY NOVÝCH ANTIEPILEPTIK
MUDr. Ivana Tyrlíková
(2/2007, Main topic ) - Acute therapy of ischemic stroke – news in mechanical trombectomy
MUDr. Kateřina Vališ, MUDr. Petra Cimflová, doc. MUDr. Jiří Vaníček, Ph.D., MUDr. Ondřej Volný, Ph.D.
(3/2020, Main topic ) - Sphingosine-1-phosphate receptor modulators in the treatment of early phase multiple sclerosis
MUDr. Marek Peterka , MUDr. Pavel Potužník, Ph.D.
(5/2023, Review articles ) - Perampanel – what to do with it?
Prof. MUDr. Ivan Rektor, CSc., MUDr. Ondrej Strýček
(3/2017, Pharmacotherapy ) - Ocrelizumab – long-term efficacy and safety in real-world clinical practice in patients with relapsingremitting multiple sclerosis
MUDr. Martin Elišák, Ph.D.
(3/2022, Review articles ) - Longterm safety of Ocrelizumab in Multiple Sclerosis treatment
MUDr. Marek Peterka , MUDr. Pavel Potužník
(4/2020, Review articles ) - Long-term efficacy and safety of ofatumumab in the treatment of multiple sclerosis
MUDr. Marek Peterka
(6/2022, Review articles ) - Eptinezumab – the new anti-CGRP monoclonal antibody for prophylactic treatment of migraine
MUDr. Rudolf Kotas, Ph.D.
(6/2022, Review articles ) - The history of treatment with botulinum toxin in the Czech Republic and Slovak Republic
Prof. MUDr. Petr Kaňovský, CSc., FEAN , prof. MUDr. Jan Benetin, Ph.D., prof. MUDr. Egon Kurča, Ph.D., FESO
(3/2026, Editorial ) - Statin myopathy
Prof. MUDr. Josef Bednařík, CSc., MUDr. Eva Vlčková, Ph.D., MUDr. Tomáš Horák
(1/2017, Main topic )
- The safety issues of anti-TNF therapy in paediatric rheumatology
doc. MUDr. Veronika Vargová, PhD.
(2/2009, Drugs & drug classes )
- Benign prostatic hyperplasia – latest pharmacotherapy options, risks and limitations of treatment
MUDr. Barbora Žemličková, MUDr. Marcela Čechová
(4/2019, Review articles ) - The actual pharmacotherapy benign hyperplasia according to EAU Guidelines
MUDr. Aleš Horák
(3/2021, Review articles ) - Comination pharmacotherapy of lower urinary tract symptoms
MUDr. Marcela Fontana, Ph.D., FEBU
(1/2024, Review articles )
- Vaccination of hematological and oncohematological patients against COVID-19
MUDr. Firas Farkaš, PhD., prof. MUDr. Angelika Bátorová, PhD.
(2/2021, Main topic ) - The role of immunotherapy in gynaecological malignancies
MUDr. Róbert Biel, PhD., MBA, doc. MUDr. Igor Andrašina, CSc.
(1/2023, Main topic ) - Targeted treatment of non-small cell lung cancer – update
MUDr. Gabriela Chowaniecová, prof. MUDr. Dalibor Ondruš, DrSc.
(4/2022, Review articles ) - Novinky z ASCO 2023, 15. ročník
MUDr. Mária Rečková, PhD.
(4/2023, Events ) - Ixazomib, lenalidomide, dexamethasone in the treatment of patients with relapsed and refractory multiple myeloma
doc. MUDr. Juraj Sokol, PhD., MUDr. Juraj Chudej, PhD., MUDr. František Nehaj, MUDr. Lenka Lisá, PhD., MUDr. Matej Hrnčár, PhD., Prof. MUDr. Ján Staško, PhD.
(3/2020, Review articles ) - Options for streamlining the administration of systemic anticancer therapy in clinical practice
PharmDr. Boris Dudík, PhD.
(4/2026, Review articles ) - Publikujeme v zahraničí
redakcia
(3/2018, Information & comments ) - Treatment of chronic lymphocytic leukemia with second-generation Bruton›s tyrosine kinase inhibitors – retrospective analysis and clinical experience
MUDr. Firas Farkaš, PhD., MUDr. Zdenka Štefániková, prof. MUDr. Angelika Bátorová, PhD.
(6/2025, Original articles ) - Recommendations for the treatment of patients with polycythaemia vera in the Slovak Republic
MUDr. Antónia Hatalová, PhD., MUDr. Alexander Wild, MUDr. Anna Vallová, MUDr. Tomáš Guman, PhD., MUDr. Monika Hlebašková, MUDr. Juraj Chudej, PhD., MUDr. Emília Flochová, PhD., MUDr. Ľubica Váleková, PhD., MUDr. Ľubica Lukáčová
(S1/2022, Supplement )
- Bezpečnost sekukinumabu v terapii psoriázy
doc. MUDr. Miloslav Salavec, Ph.D.
(3/2018, Drugs & drug classes ) - Výber abstraktov zo XIV. kongresu slovenských a českých dermatovenerológov s medzinárodnou účasťou, Jasná 2018
redakcia
(3/2018, Abstracts ) - New trends in anti-aging procedures and applications: a review of evidence, combination strategies, and safety (for dermatologists)
MUDr. Katarína Soršáková Trnovská, PhD.
(1/2026, Corrective dermatology ) - Apremilast in dermatology
MUDr. Dana Prusíková
(1/2019, Drugs & drug classes ) - Clascoterone – a new molecule in the acne treatment
MUDr. Michal Scheibenreif
(2/2026, Drugs and drug groups ) - Je potrebné si vyberať atribút liečby pri moderných terapiách psoriázy?
MUDr. Peter Kozub, PhD.
(S1 Dopĺňanie písmen v abecede psoriázy/2023, Supplement ) - Upadacitinib in the treatment of atopic dermatitis
MUDr. Karolína Vorčáková, PhD.
(2/2023, Drugs and drug groups )
- Teamwork in the analysis process medikation misconduct
prof. MUDr. Katarína Adamicová, PhD., Mgr. Dana Dolanová, PhDr. Ilona Plevová
(1/2013, Review articles )
- Depression in patients with cardiovascular disease – can be treated safely?
MUDr. Eva Kitzlerová, Ph.D.
(3/2024, Current pharmacotherapy ) - Safety treatment with statins
prof. MUDr. RNDr. Rudolf Pullmann, PhD.
(4/2013, Clinical pharmacy ) - General recommendations for safe pharmacotherapy in pregnancy in clinical practice
PharmDr. Kristína Podolská, PharmDr. Bc. Dana Mazánková, PhD., PharmDr. Mária Göböová, PhD.
(1-2/2026, Current pharmacotherapy )
- Pharmacological characteristics of apixaban
prof. MUDr. Peter Kubisz, DrSc., MUDr. Lucia Stančiaková, PhD., doc. MUDr. Miroslava Dobrotová, PhD., MUDr. Tomáš Bolek, doc. MUDr. Matej Samoš, PhD., prof. MUDr. Marián Mokáň, DrSc., FRCP Edin, Prof. MUDr. Ján Staško, PhD.
(1/2019, Main topic )
- Implementation of the Helsinki Declaration on Patient Safety in Anesthesiology in the Slovak Republic after 10 years
MUDr. Monika Grochová, PhD., MUDr. Štefan Trenkler, PhD., MUDr. Vladimír Hudák, PhD., MUDr. Jana Šimonová, PhD., MPH, MUDr. Zuzana Tatičová, doc. MUDr. Jozef Firment, PhD.
(1/2020, Guidelines ) - Implementation of activities WHO Safe surgery saves lives and Helsinki declaration into praxis
MUDr. Monika Grochová, PhD., MUDr. Štefan Trenkler, PhD., doc. MUDr. Jozef Firment, PhD., MUDr. Vladimír Hudák
(1/2013, Review articles ) - Positioning patients into the prone position in adult ICU
doc. MUDr. Jozef Firment, PhD., MUDr. Juraj Chovan, FRCA, MUDr. Monika Grochová, PhD., MUDr. JUDr. Peter Firment, MUDr. Vladimír Hudák, PhD., MUDr. Štefan Trenkler, PhD.
(1/2021, Guidelines )